Related Experiment Video
Updated: Jun 17, 2025

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
Deciphering the genetics and mechanisms of predisposition to multiple myeloma
Molly Went1, Laura Duran-Lozano2,3, Gisli H Halldorsson4
1Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK.
Abstract:
Multiple myeloma (MM) is an incurable malignancy of plasma cells. Epidemiological studies indicate a substantial heritable component, but the underlying mechanisms remain unclear. Here, in a genome-wide association study totaling 10,906 cases and 366,221 controls, we identify 35 MM risk loci, 12 of which are novel. Through functional fine-mapping and Mendelian randomization, we uncover two causal mechanisms for inherited MM risk: longer telomeres; and elevated levels of B-cell maturation antigen (BCMA) and interleukin-5 receptor alpha (IL5RA) in plasma. The largest increase in BCMA and IL5RA levels is mediated by the risk variant rs34562254-A at TNFRSF13B. While individuals with loss-of-function variants in TNFRSF13B develop B-cell immunodeficiency, rs34562254-A exerts a gain-of-function effect, increasing MM risk through amplified B-cell responses. Our results represent an analysis of genetic MM predisposition, highlighting causal mechanisms contributing to MM development.
Insights
Genetic predisposition to multiple myeloma (MM) involves longer telomeres and elevated B-cell maturation antigen (BCMA) and IL5RA levels. A specific variant in TNFRSF13B increases MM risk via amplified B-cell responses.
Area of Science:
- Genetics
- Oncology
- Immunology
Background:
- Multiple myeloma (MM) is an incurable plasma cell malignancy with a known heritable component.
- The genetic mechanisms underlying MM predisposition are not fully understood.
Purpose of the Study:
- To identify genetic loci associated with multiple myeloma (MM) risk.
- To elucidate the causal mechanisms of inherited MM risk.
Main Methods:
- Genome-wide association study (GWAS) of 10,906 MM cases and 366,221 controls.
- Functional fine-mapping and Mendelian randomization analyses.
Main Results:
- Identified 35 MM risk loci, including 12 novel loci.
- Uncovered two causal mechanisms: longer telomeres and elevated plasma levels of B-cell maturation antigen (BCMA) and IL5RA.
- The risk variant rs34562254-A at TNFRSF13B mediates increased BCMA and IL5RA, conferring a gain-of-function effect that amplifies B-cell responses and increases MM risk.
Conclusions:
- Genetic predisposition to MM is linked to specific molecular pathways.
- Understanding these genetic factors, such as TNFRSF13B variants, offers insights into MM pathogenesis and potential therapeutic targets.
More Related Videos
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
06:33Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
Published on: November 10, 2023
Related Concept Videos
Abnormal Proliferation
Cancers Originate from Somatic Mutations in a Single Cell
Cancer Prevention
Some...
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Lethal Alleles
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Differentiation of Common Myeloid Progenitor Cells